EMA
approval
· 2012-10-19
European Medicines Agency recommends approval of first higher-strength insulin for treatment of patients with diabetes mellitus in the EU
Summary
EMA recommends approval of the first higher-strength insulin to treat diabetes mellitus in the EU, expanding options for insulin therapy.
Upgrade for the full analysis, importance score, and drug timeline.